What is MoleSafe?
MoleSafe operates at the intersection of dermatology and preventative medicine, providing at-risk individuals with comprehensive diagnostic care through its proprietary Skin Surveillance Program. By leveraging advanced imaging and systematic monitoring, the company addresses the critical need for early detection in skin health. Its market position is defined by a commitment to reducing the incidence of late-stage skin conditions through proactive, data-driven surveillance, effectively bridging the gap between routine dermatological check-ups and high-acuity clinical intervention.
How much funding has MoleSafe raised?
MoleSafe has raised a total of $113K across 1 funding round:
Debt
$113K
Debt (2021): $113K with participation from PPP
Key Investors in MoleSafe
PPP
Public-Private Partnership
What's next for MoleSafe?
Following this late-stage financing, MoleSafe is positioned to accelerate its operational footprint and enhance its diagnostic infrastructure. The strategic deployment of this capital will likely focus on scaling the Skin Surveillance Program to reach a broader demographic of at-risk patients while refining the underlying diagnostic algorithms. As the company transitions into this next phase of growth, the focus will remain on maintaining clinical excellence and expanding its network of diagnostic centers, ensuring that its preventative care model remains the gold standard in the industry.
See full MoleSafe company page
